Cofetuzumab pelidotin
Appearance
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized (from mouse) |
Target | protein tyrosine kinase 7 |
Clinical data | |
Other names | PF-06647020 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6774H10418N1778O2096S46 |
Molar mass | 151.7 g/mol g·mol−1 |
Cofetuzumab pelidotin (PF-06647020) (INN[1]) is a humanized monoclonal antibody designed for the treatment of cancer.
This drug was developed by Pfizer Inc.[2]